State of Tennessee, Department of Treasury
URGN icon

State of Tennessee, Department of Treasury’s UroGen Pharma URGN Stock Holding History

State of Tennessee, Department of Treasury’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-5,010
Closed -$158K – 1538
2017
Q3 		$158K Buy
+5,010
New +$111K ﹤0.01% 1450

Other funds holding URGN

MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return
HCM
Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DP
DSAM Partners London, United Kingdom $176M AUM 83.78% 1-Year Est. Return

State of Tennessee, Department of Treasury's URGN Position: Q4 2017 in Review

State of Tennessee, Department of Treasury sold out of UroGen Pharma (URGN) in Q4 2017, closing a stake of 5,010 shares — an estimated $158K sold.

State of Tennessee, Department of Treasury first reported a position in URGN in Q3 2017 and held it in 1 quarter. The position peaked at $158K in Q3 2017. 41 funds tracked by Wall St. Rank hold URGN as of Q4 2017.

  • State of Tennessee, Department of Treasury reported no remaining UroGen Pharma position as of Q4 2017 after selling out during the quarter.
  • State of Tennessee, Department of Treasury sold 5,010 UroGen Pharma shares in Q4 2017, an estimated $158K.
  • State of Tennessee, Department of Treasury first reported a position in UroGen Pharma in Q3 2017 and held it in 1 quarter.
  • State of Tennessee, Department of Treasury's UroGen Pharma position peaked at $158K in Q3 2017.
  • 41 funds tracked by Wall St. Rank held UroGen Pharma as of Q4 2017.

Based on State of Tennessee, Department of Treasury's 13F filing for Q4 2017, filed 12 Feb 2018.